Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials
Research in Social and Administrative Pharmacy, ISSN: 1551-7411, Vol: 18, Issue: 4, Page: 2559-2568
2022
- 32Citations
- 100Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations32
- Citation Indexes32
- 32
- CrossRef11
- Captures100
- Readers100
- 100
- Mentions1
- News Mentions1
- News1
Most Recent News
New Findings Reported from College of Pharmacy Describe Advances in Clinical Trial Research (Impact of Community-pharmacist-led Medication Review Programmes On Patient Outcomes: a Systematic Review and Meta-analysis of Randomised Controlled ...)
2023 JAN 16 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Hematology Daily -- Research findings on Clinical Trial Research are discussed in
Review Description
Background : The role of pharmacists has evolved over the past few decades from being product-oriented to being service-oriented. Community-pharmacist-led medication review programmes have been commissioned in different countries under different names. The services provided by general pharmacists can have a positive impact on patient health, but the impact of the services offered by community pharmacists is relatively unknown. Objective : To evaluate the effectiveness of community-pharmacist-based medication review programmes among patients with long-term conditions. Methods: The electronic databases Cochrane Library, MEDLINE and Embase were searched from their inception until January 2020 for randomised controlled trials (RCTs) published in the English language assessing the effectiveness of community-pharmacist-led medication review programmes on patients’ clinical and healthcare utilisation outcomes. Random-effects meta-analysis was used to pool data statistically, where applicable. The study protocol was published in PROSPERO (ID: CRD42020165693). Results: Forty-two reports of 40 RCTs were included in the systematic review, and 12 RCTs were included in the meta-analysis. Compared to the control, a significant improvement was noted in the community-pharmacist-based medication review group for the following outcomes: blood pressure (BP) in patients with diabetes (mean difference [MD] in systolic blood pressure [SBP]: 6.82 [95% CI -11.33, −2.32]; MD in diastolic blood pressure [DBP]: 2.13 [95% CI -3.35, −0.92]) and in the hypertension patients (MD in SBP: 6.21 [95% CI -13.26, 0.85]; MD in DBP: 2.11 [95% CI -6.47, 2.26]), HbA1c in patients with diabetes (MD -0.61; 95% CI -0.96, −0.25), and total cholesterol (TC) in patients with hyperlipidaemia (MD -0.18; 95% CI -0.32, −0.05). Conclusion: Community-pharmacist-led medication review can improve certain clinical and healthcare utilisation outcomes in patients with long-term conditions.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1551741121001637; http://dx.doi.org/10.1016/j.sapharm.2021.04.022; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85105266867&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/33965357; https://linkinghub.elsevier.com/retrieve/pii/S1551741121001637; https://dx.doi.org/10.1016/j.sapharm.2021.04.022
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know